Insights On Trial Design
-
Practical Approaches To Clinical Trial Diversity
9/9/2024
Gain insights on FDA diversity action plans, and the important role that data points play in ensuring inclusion of underrepresented populations.
-
Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis
6/10/2025
Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.
-
Recruiting & Retaining More Patients Per Site:
3/14/2025
Through Home Trial Support (HTS) services, MRN is able to enhance the accessibility of clinical trials while reducing the emotional toll on their patients suffering from loss of mobility.
-
Real-World DHT Adherence Insights And Good Practices
7/10/2025
While advances in sensors and device design are improving wearability, successful data collection still hinges on participant adherence. The session highlights why addressing this can’t be an afterthought.
-
Navigating Late-Phase Clinical Trial Enrollment: Strategies To Stay On Schedule
1/22/2026
Late-phase trial delays cause massive revenue loss. This piece outlines AI pre-screening, direct-to-patient scaling, and retention tactics to hit study goals on time and ensure market readiness.
-
5 Common Misconceptions About Mobile Visits In Clinical Trials
10/11/2024
In this article, we address five key misconceptions about mobile research services, including concerns about inconsistent nurse assignments, privacy risks, and limited applications for complex protocols.
-
Mastering The Logistics Of Mobile Nurse Visits In Global Decentralized Clinical Trials
7/12/2024
Efficient logistics planning is crucial for global DCTs. Explore strategies for managing mobile nurse visits, ensuring timely supply delivery, and navigating international regulations.
-
A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity
3/28/2025
The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.
-
Why Is Clinical Trial Patient Travel So Important?
4/28/2025
Removing travel barriers in clinical trials ensures broader access, diverse participation and stronger results, benefiting both patients and researchers alike.
-
A Guide To Streamlining Study Start-Up In Australia
9/23/2025
Discover the benefits of Australia as a premier destination for multinational sponsors looking to expedite drug development, refine trial design, and establish long-term research partnerships.